268 related articles for article (PubMed ID: 26438868)
1. Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.
Chen JT; Chen CH; Ku KL; Hsiao M; Chiang CP; Hsu TL; Chen MH; Wong CH
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13057-62. PubMed ID: 26438868
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 overexpression in oral cancer.
Coletta RD; Leme A
Oral Dis; 2016 Apr; 22(3):163-5. PubMed ID: 26662262
[No Abstract] [Full Text] [Related]
3. Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study.
Yang HY; Chu M; Zheng LW; Zwahlen RA; Luo J; Zou DH; Sun ST
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):721-8. PubMed ID: 18929994
[TBL] [Abstract][Full Text] [Related]
4. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
[TBL] [Abstract][Full Text] [Related]
6. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
7. Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.
Groeger S; Howaldt HP; Raifer H; Gattenloehner S; Chakraborty T; Meyle J
Pathol Oncol Res; 2017 Jan; 23(1):99-110. PubMed ID: 27498988
[TBL] [Abstract][Full Text] [Related]
8. B7-H3-mediated tumor immunology: Friend or foe?
Wang L; Kang FB; Shan BE
Int J Cancer; 2014 Jun; 134(12):2764-71. PubMed ID: 24013874
[TBL] [Abstract][Full Text] [Related]
9. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
[TBL] [Abstract][Full Text] [Related]
12. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer.
Fauci JM; Straughn JM; Ferrone S; Buchsbaum DJ
Gynecol Oncol; 2012 Nov; 127(2):420-5. PubMed ID: 22910694
[TBL] [Abstract][Full Text] [Related]
13. Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.
Mao L; Fan TF; Wu L; Yu GT; Deng WW; Chen L; Bu LL; Ma SR; Liu B; Bian Y; Kulkarni AB; Zhang WF; Sun ZJ
J Cell Mol Med; 2017 Sep; 21(9):2199-2210. PubMed ID: 28401653
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
[TBL] [Abstract][Full Text] [Related]
15. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma.
Wang J; Jin X; Liu J; Zhao K; Xu H; Wen J; Jiang L; Zeng X; Li J; Chen Q
J Oral Pathol Med; 2017 Oct; 46(9):766-772. PubMed ID: 28437013
[TBL] [Abstract][Full Text] [Related]
17. B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression.
Wang F; Wang G; Liu T; Yu G; Zhang G; Luan X
Cancer Invest; 2014 Jul; 32(6):262-71. PubMed ID: 24787022
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
19. Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
Liu Y; Vlatkovic L; Sæter T; Servoll E; Waaler G; Nesland JM; Giercksky KE; Axcrona K
Int J Urol; 2012 Aug; 19(8):749-56. PubMed ID: 22487487
[TBL] [Abstract][Full Text] [Related]
20. Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.
Boland JM; Kwon ED; Harrington SM; Wampfler JA; Tang H; Yang P; Aubry MC
Clin Lung Cancer; 2013 Mar; 14(2):157-63. PubMed ID: 22868219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]